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BaCKgRoUND aND aIMS: Organoids provide a power-
ful system to study epithelia in vitro. Recently, this approach 
was applied successfully to the biliary tree, a series of ductu-
lar tissues responsible for the drainage of bile and pancreatic 
secretions. More precisely, organoids have been derived from 
ductal tissue located outside (extrahepatic bile ducts; EHBDs) 
or inside the liver (intrahepatic bile ducts; IHBDs). These 
organoids share many characteristics, including expression of 
cholangiocyte markers such as keratin (KRT) 19. However, 
the relationship between these organoids and their tissues of 
origin, and to each other, is largely unknown.
appRoaCH aND ReSUltS: Organoids were derived from 
human gallbladder, common bile duct, pancreatic duct, and 
IHBDs using culture conditions promoting WNT signaling. 
The resulting IHBD and EHBD organoids expressed stem/
progenitor markers leucine-rich repeat–containing G-protein-
coupled receptor 5/prominin 1 and ductal markers KRT19/
KRT7. However, RNA sequencing revealed that organoids 
conserve only a limited number of regional-specific markers 
corresponding to their location of origin. Of particular in-
terest, down-regulation of biliary markers and up-regulation 
of cell-cycle genes were observed in organoids. IHBD and 
EHBD organoids diverged in their response to WNT sign-
aling, and only IHBDs were able to express a low level of 
hepatocyte markers under differentiation conditions.
CoNClUSIoNS: Taken together, our results demonstrate that 
differences exist not only between extrahepatic biliary organoids 
and their tissue of origin, but also between IHBD and EHBD 
organoids. This information may help to understand the tissue 
specificity of cholangiopathies and also to identify targets for 
therapeutic development. (Hepatology 2021;73:247-267).
The biliary tree is a series of ductular tissues lined by epithelial cells called cholangiocytes. It is responsible for the drainage, storage, and 
concentration of bile produced by the liver and pan-
creatic secretions from the pancreas.(1) The biliary tree 
is broadly divided into two compartments: intra- and 
extrahepatic.(1,2) The intrahepatic compartment is fur-
ther divided based on duct size, whereas the extrahe-
patic compartment is divided by anatomical region, 
including the common hepatic duct, gallbladder 
(GBD), cystic duct, common bile duct (CBD), and 
pancreatic duct (PancD).(2) Embryologically, these 
compartments arise from different precursor cells.(3) 
Intrahepatic cholangiocytes arise from bipotent hepa-
toblasts, whereas extrahepatic cholangiocytes share an 
embryologic origin with the ventral pancreas.(3)
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Research on cholangiocytes has historically focused 
on the intrahepatic compartment.(4,5) Analysis of intra-
hepatic bile ducts has demonstrated the existence of two 
populations of cholangiocytes: small and large, which 
respectively line the smallest intrahepatic ductules and 
the larger intrahepatic ducts.(4,5) It has been shown 
that large and small cholangiocytes display different 
transcriptional profiles, proliferative capacity, and bio-
logical function.(4,5) On the other hand, little is known 
about the diversity that may exist between individual 
anatomical regions of the extrahepatic compartment. 
This understanding is critical given that human chol-
angiopathies, such as biliary atresia, primary sclerosing 
cholangitis, and nonanastomotic biliary strictures, show 
regionalization and preferentially target extrahepatic 
bile ducts (EHBDs) early in disease.(6-8)
Additionally, it has been demonstrated that in vitro 
three-dimensional (3D) culture of human biliary organ-
oids is possible from both intra- and extrahepatic tis-
sues.(9-12) However, it remains unclear whether the 
extrahepatic cultures contain stem/progenitor popula-
tions. Huch et al. isolated human intrahepatic bile ducts 
(IHBDs) in conditions promoting canonical WNT 
signaling. These resulting IHBD organoids were capa-
ble of long-term expansion and bipotential differenti-
ation toward either hepatocyte or biliary fates.(9) This 
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work suggested the presence of an intrahepatic stem/ 
progenitor population. Using a similar WNT-based 
system, Lugli et al. established both mouse and human 
GBD organoids.(11) However, differentiation capacity 
was only assessed for the murine organoids and showed 
incomplete differentiation toward a hepatocyte fate with 
no in vivo differentiation potential.(11) Furthermore, our 
group recently demonstrated that human cholangiocyte 
organoids from CBD and GBD, grown in the absence of 
canonical WNT, were capable of long-term expansion, 
yet lacked characteristic markers of adult stem cells, such 
as leucine-rich repeat–containing G-protein-coupled 
receptor 5 (LGR5) and prominin 1 (PROM1).(12) The 
differentiation capacity of these organoids beyond a bil-
iary fate was not assessed in vitro; however, these cells 
never generated hepatocytes after transplantation in 
mouse models.(12,13) Together, these reports suggest that 
both intra- and extrahepatic human cholangiocytes are 
capable of forming 3D-organoid cultures, which, under 
certain conditions, display adult stem/progenitor pheno-
types. However, it is unclear whether EHBD organoids 
are capable of bipotential differentiation like IHBD 
organoids. Additionally, how EHBD organoids from 
different anatomical regions of the biliary tree compare 
to each other, their tissue of origin, and IHBD organ-
oids is also unknown. Here, we report the derivation and 
characterization of human biliary organoids from three 
regions of the human extrahepatic biliary tree: CBD, 
GBD, and PancD. We demonstrate that these EHBD 
organoids, when grown in conditions promoting canon-
ical WNT signaling, express markers of adult stem cells, 
such as LGR5 and PROM1. Furthermore, we demon-
strate that primary extrahepatic tissues display unique 
transcriptional signatures depending on anatomical ori-
gin. We also show that EHBD organoids maintain a 
limited number of these tissue-specific differences. Last, 
we compare our EHBD to IHBD organoids and show 
that only IHBD organoids have the capacity to express 




Human GBD, CBD, PancD, and liver samples 
were obtained from organ donors at either Cambridge 
University Hospitals or the Royal Infirmary of 
Edinburgh (REC reference: 16/WM/0093, 15/
EE/0152). CBD, PancD, and IHBD organoid cell 
lines were derived from either liver or pancreas donors 
deemed unsuitable for transplant. GBD organoids 
were derived from livers deemed unsuitable or suitable 
for transplant, given that the GBD is not routinely 
retransplanted. Generally, the liver and pancreas were 
considered unsuitable for transplant because of exces-
sively long ischemia time or evidence of disease (i.e., 
fatty liver or pancreatic calcifications). Informed con-
sent for the use of tissues for research purposes was 
obtained from each donor’s next of kin, and protocols 
were reviewed and approved by the ethics committees 
at both hospitals and consent recorded according to 
the National Health Service Blood and Transplant 
consent regulation (FRM 1538). Tissue samples were 
stored at 4°C in University of Wisconsin Solution. 
Donor demographics are listed in Supporting 
Table S1.
eXtRaHepatIC pRIMaRy 
epItHelIUM ISolatIoN aND 
oRgaNoID CUltURe
GBD samples were received as either whole GBDs 
or small 2-cm2 tissue segments. Whole GBDs were 
drained of bile and the neck discarded. A longitudinal 
incision was used to expose the GBD mucosal surface. 
CBD and PancD samples were received intact and the 
wall of the ducts incised with a scalpel to expose the 
lumen. Tissues were washed three times with cold 
Hank’s balanced salt solution. Tissues were transferred 
to cold advanced (ADV)/Dulbecco’s modified Eagle’s 
medium (DMEM)-F12 with 100 U/mL of penicillin 
and 100 μg/mL of streptomycin. The mucosal surface 
was then abraded with a scalpel to mechanically disso-
ciate the epithelium (Fig. 1A). Dissociated epithelium 
was centrifuged at 300g for 5 minutes, washed twice 
and then either lysed for primary RNA or used for 
organoid derivation. For organoid derivation, epithe-
lium was resuspended in growth factor reduced (GFR) 
Matrigel. Droplets (50 μL) were plated per well into 
a 24-well plate. Matrigel was allowed to solidify for 
5-10 minutes at 37°C before adding 500 μL of ADV/
DMEM-F12 containing 1× N2 serum-free sup-
plement, 1× B27 serum-free supplement, 2  mM of 
l-glutamine, 100 U/mL of penicillin, and 100 μg/mL 
of streptomycin. The following growth factors 
were added: 20% R-spondin conditioned media or 
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500  ng/mL of recombinant human R-spondin 1 
(RSPO-1), 3  μM of CHIR 99021, 100  ng/mL of 
recombinant human Noggin, 2.5  μM of prostaglan-
din E2 (PGE2), 100  ng/mL of recombinant human 
epidermal growth factor (EGF), 5  μM of A 83-01, 
and 10 μM of forskolin (FSK). For the first 48 hours, 
10 μM of Y-27632 was added to the media. Media was 
changed every 2-3  days. Within 24-48  hours, cystic 
organoid structures were observed. Organoids reached 
confluence after 5-10  days and were split using the 
procedure below. Cells could be readily freeze/thawed 
using Cell Banker 2.
INtRaHepatIC BIle DUCt 
ISolatIoN aND oRgaNoID 
CUltURe
Liver tissue (2  ×  2  cm2) was frozen in Cell 
Banker 2 and stored at −80°C. Tissue was thawed 
at 37°C and then minced in a 10-cm2 plate. Tissue 
fragments were placed in 20 mL of digestion media 
consisting of DMEM high glucose + GlutaMAX 
with 1% fetal calf serum (FCS), 100 U/mL of pen-
icillin, 100  μg/mL of streptomycin, 128.4  μg/mL 
of dispase II, and 128.4 μg/mL of collagenase from 
Clostridium histolyticum. Tissue was digested for 
4-5  hours. Ducts were picked under a microscope, 
then placed in DMEM high glucose + GlutaMAX 
with 5% FCS. Ducts were centrifuged for 5 minutes 
at 200g. Ducts were resuspended in GFR Matrigel, 
and 50-μL droplets were plated in a 24-well plate, 
allowed to solidify at 37°C, and overlaid with 
500 uL of one of two media: (1) extrahepatic media 
as described above with 10  μM of Y-27632 or (2) 
intrahepatic isolation media for 3 days, after which 
the media was changed to intrahepatic expansion 
media as described.(9,14) See Supporting Table S2 for 
all reagents and manufacturers used in cell culture.
oRgaNoID paSSagINg
Extrahepatic organoids were split every 5-10  days 
at a ratio of 1:2-1:4. Organoids were incubated 
in cell recovery solution for 30  minutes at 4°C. 
Extrahepatic organoids were washed two times with 
ADV/DMEM-F12 and pelleted at 300g for 4  min-
utes. Extrahepatic organoids were then dissociated 
with a p1000 pipette, resuspended in fresh Matrigel, 
and replated as above. The media was supplemented 
with 10  μM of Y-27632 for 48  hours after splitting. 
Intrahepatic organoids were subjected to the same 




See the Supporting Materials and Methods for 
details on immunocytochemistry, flow cytometry, 
qPCR, and RNA sequencing (RNA-Seq). A list of 
antibodies and primers can be found in Supporting 
Tables S3 and S4.
StatIStICal aNalySeS
Statistical analyses were carried out in Prism soft-
ware (version 7; GraphPad Software Inc., La Jolla, 
CA). An unpaired t test or one-way analyses of 
variance (ANOVAs) were performed followed by 
FIg. 1. Derivation of extrahepatic organoids expressing biliary and stem/progenitor markers. (A) Diagram depicting the mechanical 
isolation used to obtain biliary epithelial cells, image showing the cells recovered, and representative images of organoids isolated from 
CBD, GBD, or PancD. Scale bars, 1,000 μm. (B) Representative flow cytometry analysis of mechanically dissociated epithelium from 
human GBD showing percentage of cells expressing KRT7 and KRT19 (black). Negative control: secondary antibody only (gray). 
(C) Representative image of deteroriated GBD organoid cultures derived without A 83-01 and FSK that were rescued after 48 hours of 
treatment with A 83-01 and FSK (scale bars, 1,000 μm). Graph showing clonality of EHBD organoids grown with or without A 83-01 
and FSK (mean and SEM; n = 9 independent experiments, n = 3 donors; unpaired t test). (D) Representative flow cytometry analysis 
of CBD organoids showing percentage of cells expressing KRT7 and KRT19 (black). Negative control: secondary antibody only (gray). 
(E) Clonality assay showing the number of organoids formed per 1,000 single cells for PancD, CBD, and GBD organoids (mean and 
SEM; n = 3 independent experiments, n = 1 donor line per EHBD region; one-way ANOVA) and representative images of a single cell 
forming an organoid over 7 days. (F) qPCR showing expression of biliary and adult stem cell markers in EHBD organoids or tissue 
samples from CBD, GBD, and PancD. Organoids derived from human sigmoid colon (SC; n = 4), primary hepatocytes (PH; n = 4), and 
H9 embryonic stem cells (H9; n = 3) were used as controls. Gene expression is normalized to UBC and plotted as mean and SEM. CBD 
tissue (n = 5), CBD organoids at P5 (n = 7), GBD tissue (n = 5), GBD organoids at P5 (n = 7), PancD tissue (n = 3), and PancD organoids 
at P5 (n = 3); one-way ANOVA. *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001; ****P ≤ 0.0001. If not otherwise indicated, comparisons between groups 
were not significantly different (P > 0.05). Abbreviations: APC, allophycocyanin; FITC, fluorescein isothiocyanate; UBC, ubiquitin C.
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post-hoc analyses, using either Dunnett’s, Tukey’s, or 
Sidak’s multiple comparisons tests.
Results
DeRIVatIoN oF eXtRaHepatIC 
BIle DUCt oRgaNoIDS IN 
CoNDItIoNS pRoMotINg WNt 
SIgNalINg
In the course of our previous experiments, we noted 
that extrahepatic cholangiocytes cultured as organoids 
(extrahepatic cholangiocyte organoids; ECOs) in the 
presence of RSPO-1, dickkopf WNT signaling path-
way inhibitor 1 (DKK-1; a canonical WNT inhibitor), 
and EGF were capable of long-term expansion, but did 
not express characteristic stem/progenitor markers such 
as LGR5 and PROM1.(12) Thus, ECOs seemed to fun-
damentally differ from organoids derived from IHBDs, 
which do express these markers.(9) In parallel, we also 
observed that growing ECOs in the presence of CHIR 
99021, a small-molecule inhibitor of glycogen synthase 
kinase 3 beta (GSK3β), resulted in lower levels of phos-
phorylated ß-catenin and thus a higher level of WNT 
activity.(12) Given these observations, we decided to test 
a culture media that promotes canonical WNT signal-
ing. We hypothesized that this media would promote a 
progenitor phenotype in extrahepatic biliary organoids 
more closely resembling that of intrahepatic organoids. 
The resulting cells were designated biliary organoids, 
instead of cholangiocyte organoids, to underline this 
difference. Mechanical dissociation was used to isolate 
biliary epithelium from human CBD, GBD, and PancD 
(Fig. 1A), which allows the recovery of a near homoge-
nous population of cells coexpressing the cholangiocyte 
markers, keratin (KRT) 7/KRT19 (94.7% ± 4.31%; 
mean ± SD; n  =  2; Fig. 1B). The resulting cells were 
then grown in 3D Matrigel supplemented with RSPO-
1, CHIR 99021, Noggin, PGE2, EGF, A 83-01, and 
FSK. Importantly, addition of both A 83-01 (transform-
ing growth factor [TGF-β] inhibitor) and FSK (cAMP 
activator) were important for maintaining organoid cul-
tures (Fig. 1C).(9) Flow cytometry analyses on GBD 
and CBD, organoids demonstrated coexpression of 
KRT19 and KRT7 (95.04 ± 2.09% of cells; n = 5; Fig. 
1D and Supporting Fig. S1). In total, seven CBD lines, 
nine GBD lines, and three PancD lines were derived in 
these conditions from donors ranging in age from 20 
to 68  years (Supporting Table S1), with 100% of the 
tissue samples yielding organoids. Organoids displayed 
similar morphology and growth dynamics regardless of 
their tissue of origin and could not be readily distin-
guished from one another (Fig. 1A). Organoids from 
all three regions demonstrated a similar capacity for 
single-cell clonality, with an average of 1.4% of single 
cells reforming organoids (Fig. 1E). In the absence of A 
83-01 and FSK, this was significantly reduced to 0.5% 
(Fig. 1C). qPCR demonstrated that EHBD organoids 
expressed adult stem/progenitor markers (LGR5 and 
PROM1), ductal markers (SRY-box transcription fac-
tor 9 [SOX9], KRT7, and hepatocyte nuclear factor 1 
beta [HNF1B]), and early hepatocyte markers (T-box 3 
[TBX3], hepatocyte nuclear factor 4 alpha [HNF4A]), 
but not the hepatocyte marker, albumin (ALB; 
Fig. 1F), and that the majority of these markers remained 
consistently expressed over time in culture (Supporting 
Fig. S2). Levels of ductal markers in EHBD organ-
oids were comparable to or greater than tissue, with 
the exception of the mature biliary marker, HNF1B, 
which was reduced in EHBD organoids. The stem/
progenitor markers, LGR5/PROM1 and TBX3, were 
significantly enriched in EHBD organoids compared to 
tissue. Immunofluorescence (IF) of Ki67 demonstrated 
that a substantial fraction of cells were actively prolifer-
ating (Fig. 2A-C and Supporting Fig. S3). Interestingly, 
primary tissues had no detectable levels of Ki67 (Fig. 
2A-C and Supporting Fig. S4), suggesting that prolifer-
ation is extremely rare in the biliary epithelium. Finally, 
both organoids and tissues uniformly expressed epithe-
lial cell adhesion molecule (EPCAM), SOX9, KRT19, 
HNF4A, and KRT7 (Fig. 2A-C and Supporting Figs. 
S3 and S4). Taken together, these results demonstrate 
that biliary organoids can be derived from multiple, dis-
tinct regions of the extrahepatic biliary tree and that the 
promotion of canonical WNT signaling is associated 
with expression of stem/progenitor markers in these 
organoids.
tRaNSCRIptoMIC pRoFIlINg 
oF pRIMaRy eXtRaHepatIC 
BIlIaRy epItHelIUM ReVealS 
DIStINCt SIgNatUReS BetWeeN 
aNatoMICal RegIoNS
To assess what differences may exist between 
organoids and their region of origin, we first decided 
to establish a transcriptional profile of primary CBD, 
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FIg. 2. Extrahepatic tissues and organoids express biliary markers and show histological similarities. Representative IF images of EHBD 
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GBD, and PancD epithelium. RNA-Seq was per-
formed on epithelial-enriched samples from each 
tissue region. Of note, these epithelial cells were col-
lected as described for organoid derivation without 
any purification step to avoid cellular stress associated 
with cell sorting. Thus, we cannot exclude limited 
contamination by nonbiliary cell types. Accordingly, 
hormonal markers could be detected in PancD 
samples (i.e., pancreatic polypeptide, somatostatin; 
Supporting File S1). Nonetheless, expression of biliary 
markers, such as KRT7, KRT19, and EPCAM, could 
be detected at a similar level across the three tissues, 
confirming enrichment of ductal epithelium. Based 
on this observation, we performed principal com-
ponent analysis (PCA), which revealed clustering of 
samples by tissue type (Fig. 3A). Further, differential 
gene expression (DGE) analyses demonstrated that a 
number of genes were differentially expressed between 
tissues (Fig. 3B; Supporting File S1), thus uncover-
ing regional-specific markers. Overall, 419 genes were 
determined to be GBD specific, 967 PancD specific, 
and 256 CBD specific (Fig. 3B; Supporting File S2). 
In addition, we performed hierarchical clustering 
using these markers and show that both the samples 
and genes cluster by tissue, further validating their 
regional specificity (Fig. 3C). Gene Ontology (GO) 
analyses on tissue-specific genes and also genes differ-
entially expressed between pairs of tissues highlighted 
potential functional differences between the regions (a 
full list of GO terms for all comparisons below can be 
found in Supporting File S3). Of particular interest, 
GBD tissue was enriched in genes (i.e., UDP glucu-
ronosyltransferase family 1 member A6 [UGT1A6], 
monoacylglycerol O-acyltransferase 1 [MOGAT1], 
carbonic anhydrase 4, SRY-box transcription factor 17 
[SOX17], and vitamin D receptor [VDR]) involved 
in xenobiotic, lipid, carbohydrate, and steroid metab-
olism (Fig. 3D and Supporting Fig. S5A,B). Genes 
up-regulated in PancD tissue (i.e., secretin recep-
tor and caudal-related homeobox 2 [CDX2]) were 
involved in protein targeting and localization to the 
membrane or endoplasmic reticulum (Fig. 3E and 
Supporting Fig. S5C,D). CBD-specific genes (i.e., 
homeobox B2 [HOXB2], homeobox B3 [HOXB3], 
and ATP-binding cassette subfamily A member 1 
[ABCA1]) were involved in tissue morphogenesis 
and signal transduction (Fig. 3F and Supporting Fig. 
S5E,F). Finally, we looked at genes up-regulated in 
both GBD and CBD, compared to PancD, tissue 
and found 856 overlapping genes (Supporting Fig. 
S5G,H; Supporting File S2). This list included genes 
involved in lipid, cholesterol, bile acid, and bilirubin 
metabolism (i.e., [FGF19], [NR1I2], VDR, UDP glu-
curonosyltransferase family 1 member A4, UGT1A6, 
UDP glucuronosyltransferase family 1 member A10, 
ABCA1, apolipoprotein A1, and peroxisome prolif-
erator-activated receptor gamma), all components of 
bile, which is only in contact with GBD/CBD epithe-
lium and not the PancD. Taken together, these data 
suggest that the anatomical region could shape the 
expression profile of cholangiocytes within the biliary 
tree.
tRaNSCRIptoMIC pRoFIlINg 
oF eXtRaHepatIC BIlIaRy 
oRgaNoIDS ReVealS 
DoWN-RegUlatIoN oF 
CHolaNgIoCyte MaRKeRS aND 
Up-RegUlatIoN oF Cell-CyCle 
aND WNt taRget geNeS
Having generated the transcriptional profile of the 
three regions of the extrahepatic biliary tree, we next 
investigated how EHBD organoids compare to their 
tissue of origin. To do so, we performed RNA-Seq 
on passage 5 organoids, derived from CBD, GBD, 
and PancD, and compared their transcriptional pro-
file to those of primary tissues. PCA revealed that the 
largest source of variation in the samples (56%) was 
between tissues and organoids, whereas tissue-specific 
FIg. 3. Gene expression profile of extrahepatic tissues uncovered regional-specific markers and functions. (A) PCA of variance stabilized 
counts for the top 5,000 most variable genes between CBD (n = 7), GBD (n = 5), and PancD (n = 3) tissues. (B) Venn diagrams showing 
the number, as well as overlap, of genes up-regulated in either GBD, CBD, or PancD tissues in comparison to each of the other two. (C) 
Heatmap of the tissue-specific genes up-regulated in CBD compared to both GBD and PancD tissues (n = 256 genes), GBD compared 
to both PancD and CBD tissues (n = 419 genes), and PancD compared to both CBD and GBD tissues (n = 967 genes). (D-F) Top 10 
most significant gene ontologies (biological process) for genes up-regulated in GBD tissue compared to both CBD and PancD (D); 
PancD tissue compared to both CBD and GBD (E); only five terms were significantly enriched in CBD tissue compared to both GBD 
and PancD (F). Abbreviations: ER, endoplasmic reticulum; rRNA, ribosomal RNA.
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differences only accounted for 10% of variation 
between samples (Fig. 4A). Furthermore, DGE anal-
yses showed that a large number of genes were dif-
ferentially expressed between each organoid type and 
its corresponding tissue of origin (Fig. 4B; Supporting 
File S4). To further understand these differences, 
we examined the expression levels of selected genes 
involved in mature biliary function, adult stem/pro-
genitors, WNT signaling, and cell cycle, which were 
differentially expressed between organoids and tis-
sues (Fig. 4C). Hierarchical clustering of these genes 
highlighted the differences between organoids and 
tissues. We observed the induction of known WNT 
target genes (i.e., LGR5/6, AXIN2, minichromosome 
maintenance complex component 2, SRY-box tran-
scription factor 4, MYC proto-oncogene [MYC], and 
transcription factor 7 [TCF7]), but also an increase in 
stem/progenitor markers not regulated by WNT (i.e., 
ATP-binding cassette subfamily C member 1, actin fil-
ament-associated protein 1, neural cell adhesion mole-
cule, PROM1, TUB-like protein 3, helicase, lymphoid 
specific, and chloride intracellular channel 4) shown 
previously to be expressed in intestinal stem cells and 
liver progenitor cells (Supporting Fig. S6E; Supporting 
File S5).(15,16) No induction of pluripotency genes 
(i.e., NANOG, octamer 4, and SRY-box transcription 
factor 2) was observed. On the other hand, organoids 
displayed significantly lower expression of functional 
biliary markers (i.e., gamma-glutamyltransferase 
[GGT] 1/6, cystic fibrosis transmembrane conductance 
regulator [CFTR], mucin 1, cell-surface associated 
[MUC1], and vasoactive intestinal polypeptide recep-
tor 1 [VIPR1]; Fig. 4C). Thus, our culture condi-
tions, and the activation of WNT signaling, seem to 
promote a progenitor profile. Of note, ductal mark-
ers, such as KRT7, KRT19, EPCAM, and SOX9, 
were not differentially expressed between tissues and 
organoids, suggesting that these genes are intrinsic 
biliary markers and not affected by WNT or in vitro 
conditions. Furthermore, GO analyses of the top 200 
differentially expressed genes (genes with the smallest 
false discovery rate) between organoids and their cor-
responding tissues were enriched for terms involved 
in cell-cycle process and cell division. Genes up- 
regulated in tissues compared to organoids were 
enriched for GO terms involved in secretion, trans-
port, and metabolic processes (Fig. 4D and Supporting 
Fig. S7; Supporting File S6). We also assessed whether 
any regional tissue-specific signatures were maintained 
in EHBD organoids. It was found that only 45% of 
significantly differentially expressed genes between 
CBD-, GBD-, and PancD-derived organoids over-
lapped with differentially expressed genes previously 
identified in their corresponding primary tissues 
(Fig. 4E; Supporting Files S7 and S8). However, 
91.6% of these genes showed the same directionality 
of expression when comparing organoid and tissue 
expression patterns. This suggests that EHBD organ-
oids, despite differing from their tissue of origin, do 
maintain some regional-specific markers in culture. 
FIg. 4. Comparison of the transcriptional profile of EHBD organoids and tissues suggest down-regulation of functional biliary markers, 
up-regulation of WNT and cell-cycle pathways, and minimal maintenance of regional-specific markers after in vitro culture. (A) PCA 
of variance stabilized counts for the top 5,000 most variable genes between CBD tissue (n = 7), CBD organoids (n = 6), GBD tissue 
(n  =  5), GBD organoids (n  =  3), PancD tissue (n  =  3), and PancD organoids (n  =  3). (B) Venn diagram showing the number, and 
overlap, of genes differentially expressed between CBD tissue and organoids, PancD tissue and organoids, or GBD tissue and organoids. 
(C) Heatmap of selected biliary and adult stem cell/WNT pathway genes. (D) Top 10 most significant gene ontologies (biological process) 
for the top 200 differentially expressed genes up-regulated in extrahepatic tissues compared to organoids or up-regulated in extrahepatic 
organoids compared to tissues. (E) Venn diagrams displaying number, as well as overlap, of genes differentially expressed comparing: GBD 
versus PancD tissues and organoids; CBD versus PancD tissues and organoids; and CBD versus GBD tissues and organoids. (F) RNA-
Seq normalized counts and qPCR validation of three genes found to retain tissue-specific expression patterns in organoids. For qPCR 
validation: CBD tissue (n = 6), CBD organoids (n = 7), GBD tissue (n = 10), GBD organoids (n = 7), PancD tissue (n = 3), and PancD 
organoids (n = 3) and gene expression were normalized to UBC, and data were plotted as mean and SEM; one-way ANOVA. Sigmoid 
colon (SC) organoids (n = 4) were used as controls. *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001; ****P ≤  0.0001; n.s. = not significant. (G) IF of EHBD 
organoids and tissues for two genes found to be tissue specific. Abbreviations: ABCC3, ATP-binding cassette subfamily C member 3; 
ADCY5, adenylate cyclase 5; ALP1, alkaline phosphatase 1, isoform A; ALPL, alkaline phosphatase, biomineralization associated; AQP1, 
aquaporin 1; AQP4, aquaporin 4; CDCA7, cell division cycle-associated 7; CDK6, cyclin-dependent kinase 6; DKK3, dickkopf WNT 
signaling pathway inhibitor 3; EPHB2, ephrin type-B receptor 2; FZD6, frizzled class receptor 6; FZD7, frizzled class receptor 7; LAP6, 
less adhesive pollen 6; ONECUT1, one cut homeobox 1; ONECUT2, one cut homeobox 2; PDK1, pyruvate dehydrogenase kinase 1; 
RNF43, ring finger protein 43; SLC4A4, solute carrier family 4 member 4; SLC9A1, solute carrier family 9 member A1; SLC10A2, solute 
carrier family 10 member 2; TCF3, transcription factor 3; UBC, ubiquitin C; ZNRF3, zinc and ring finger 3.
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Of note, expression of three of these genes—SOX17, 
CDX2, and HOXB2 (Fig. 4F,G and Supporting Fig. 
S8)—were validated using qPCR and/or IF. SOX17 
was only expressed in GBD tissue whereas CDX2 
and HOXB2 were exclusively expressed in PancD 
and CBD tissues, respectively. These expression pat-
terns did not change significantly over time in culture 
(Supporting Fig. S9), although CBD organoids did 
show expression of SOX17 at the protein level despite 
minimal levels by qPCR (Fig. 4G and Supporting Fig. 
S8). Taken together, these data show that biliary epi-
thelial cells lose, in part, their regional identity when 
grown as organoids in the presence of WNT signal-
ing. Nonetheless, this “dedifferentiation” seems to be 
only partial given that expression of a few, but very 
specific, regional markers are maintained in EHBD 
organoids.
INtRaHepatIC BIle DUCt 
oRgaNoIDS CaNNot Be 
MaINtaINeD IN eXtRaHepatIC 
CUltURe CoNDItIoNS 
pRoMotINg CaNoNICal WNt
We next sought to establish organoids from 
IHBDs using the same culture conditions used 
to derive EHBD organoids. For that, liver tissue 
obtained from deceased transplant organ donors was 
subjected to enzymatic dissociation, and the resulting 
cells were grown in the conditions described above 
(Fig. 5A). The resulting organoids (IHBD_CHIR) 
grew well for the first 2-3  weeks. Interestingly, 
IHBD_CHIR organoids were morphologically 
distinct from EHBD organoids (Supporting Fig. 
S10A), displaying a heterogeneous appearance, with 
some organoids having cryptic/budding structures, 
whereas others maintained a cystic structure similar 
to EHBD organoids. After five to seven passages, 
these cryptic structures began to predominate, prolif-
eration ceased, and cultures could not be maintained. 
Given this result, we also isolated IHBD organoids 
in conditions published by Huch et al.(9) The result-
ing organoids (IHBD_NO CHIR) maintained their 
proliferative ability for at least 10 passages without 
evidence of deterioration (Fig. 5B) while displaying 
a homogenous cystic morphology. qPCR analyses 
of EHBD, IHBD_CHIR, and IHBD_NO CHIR 
organoids revealed only minor differences in expres-
sion of biliary and stem/progenitor markers (Fig. 
5C). IF confirmed that, similarly to EHBD organ-
oids, IHBD organoids expressed EPCAM, SOX9, 
KRT19, and KRT7 (Fig. 5D and Supporting Fig. 
S11). Of note, IHBD organoids did express HNF4A 
whereas this transcription factor was absent from 
primary IHBD tissue. Ki67 expression was pres-
ent in the majority of cells in IHBD_NO CHIR 
organoids, but was variable in IHBD_CHIR organ-
oids, and absent in primary tissue (Fig. 5D and 
Supporting Fig. S10B). Additional investigations 
revealed that the presence of CHIR 99021 in media 
was likely responsible for the divergence between 
IHBD_CHIR and IHBD_NO CHIR organoids 
(Fig. 6A and Supporting Fig. S12).
Established IHBD_NO CHIR organoids were dis-
sociated into single cells and transferred into EHBD 
media containing CHIR 99021 or into IHBD media 
containing CHIR 99201, IWP2, DKK, or IHBD 
media without A 83-01/FSK (Fig. 6B,C). Promoting 
canonical WNT or TGFβ pathways significantly 
reduced the clonality of IHBD_NO CHIR organ-
oids, suggesting that these factors are detrimental to 
the self-renewal of intrahepatic biliary cells. Similar 
experiments were performed with EHBD organoids, 
and the presence or absence of CHIR 99021 had lit-
tle effect on their clonality. Interestingly, inhibition of 
WNT signaling with IWP2 or DKK had little impact 
on either IHBD_NO CHIR or EHBD organoids 
(Fig. 6D,E and Supporting Fig. S10C), suggesting 
that the canonical WNT pathway is not necessary for 
cholangiocytes to proliferate in vitro. Taken together, 
FIg. 5. Intra- and extrahepatic organoids display divergent characteristics. (A) Diagram depicting the isolation procedure for IHBDs 
and image showing an isolated duct. (B) Images showing IHBD organoids grown in either Huch et al. conditions (IHBD_NO CHIR) 
or extrahepatic culture conditions (IHBD_CHIR) at passage 0 or at passage 5. Scale bars, 1,000 μm. (C) qPCR of IHBD_CHIR (n = 3) 
and IHBD_NO CHIR (n = 3) organoids in comparison to EHBD organoids from CBD (n = 7), GBD (n = 7), and PancD (n = 3) at 
passage 5. Primary hepatocytes (PH; n = 4), sigmoid colon organoids (SC; n = 4), and H9 embryonic stem cells (H9; n = 3) were used as 
controls. Gene expression was normalized to UBC, and data were plotted as mean and SEM. *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001; ****P ≤  
0.0001. If not otherwise indicated, comparisons between groups were not significantly different (P > 0.05); one-way ANOVA. (D) IF 
of IHBD_CHIR, IHBD_NO CHIR, and primary liver tissue for selected markers. Scale bars, 50 μm. Abbreviation: UBC, ubiquitin C.
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these data demonstrate that cells from the extra- and 
intrahepatic biliary tree could diverge in their response 
to canonical WNT. Indeed, continuous activation 
of canonical WNT signaling appears detrimental to 
the proliferation and self-renewal of IHBD, but not 
EHBD, organoids. However, this difference seems to 
have little consequence on the expression of biliary 
markers.
Hepatology, Vol. 73, No. 1, 2021 RIMLAND ET AL.
261
INtRa- aND eXtRaHepatIC 
oRgaNoIDS DISplay DIFFeReNt 
tRaNSCRIptIoNal pRoFIleS
In addition to performing the basic characteriza-
tions of our EHBD and IHBD organoids, we also per-
formed RNA-Seq comparisons on CBD, GBD, PancD, 
IHBD_CHIR, and IHBD_NO CHIR organoids. 
PCA demonstrated that the largest source of variation 
was between EHBD and IHBD organoids. EHBD 
organoids clustered closely together regardless of their 
tissue of origin, whereas both IHBD_CHIR and 
IHBD_NO CHIR clustered separately from EHBD 
organoids and each other (Fig. 7A). Correlation analy-
sis further confirmed this (Fig. 7B). Given that all of the 
EHBD organoid types clustered closely and the num-
ber of genes differentially expressed between the three 
organoid types was minimal in our earlier analyses, we 
combined them into a single “EHBD” group for further 
analyses. We then sought to understand the transcrip-
tional divergence between IHBD_CHIR, IHBD_NO 
CHIR, and EHBD organoids. A total of 2,122 genes 
were differentially expressed between IHBD_CHIR 
and IHBD_NO CHIR organoids, whereas 2,990 
genes were differentially expressed between IHBD_
CHIR and EHBD organoids. Of note, 544 genes were 
up-regulated in both IHBD_NO CHIR and EHBD 
organoids compared to IHBD_CHIR organoids 
(Fig. 7C; Supporting File S9). As expected, given the 
proliferation differences observed between the organ-
oids, these genes were enriched significantly for two 
GO terms, including mitotic cell-cycle process (adjusted 
P value  =  4.01E10−2) and cell-cycle process (adjusted 
P value = 4.06E10−2). Interestingly, 612 genes were 
up-regulated in IHBD_CHIR organoids compared 
to both IHBD_NO CHIR and EHBD organoids. 
These genes included hepatocyte (i.e., ALB, trans-
thyretin [TTR], nuclear receptor subfamily 1 group 
H member 4 [NR1H4], cytochrome P450 family 7 
subfamily B member 1 [CYP7B1], and complement/
clotting factors), stem/progenitor (i.e., PROM1, 
secreted phosphoprotein 1 [SPP1]), and cell death/
senescence/epithelial mesenchymal transition (i.e., 
caspase-1 [CASP1], vimentin [VIM]) markers 
(Fig. 7D). Thus, this analysis suggests complex differ-
ences between these organoids without uncovering a 
major source of divergence.
We next sought to more broadly understand the 
differences between IHBD and EHBD organoids. 
Given the transcriptional signature of the IHBD_
CHIR organoids and their known proliferative dif-
ference, we focused these comparisons on EHBD 
and IHBD_NO CHIR organoids. A total of 1,393 
genes were differentially expressed between EHBD 
and IHBD_NO CHIR organoids (Fig. 7E). The 601 
genes up-regulated in IHBD_NO CHIR organoids 
were enriched for GO terms involved with devel-
opmental processes and cell differentiation (Fig. 7F; 
Supporting File S10) Interestingly, these genes 
included the hedgehog pathway ligands, Indian 
hedgehog (IHH) and Sonic hedgehog (SHH), 
which have been shown to promote the maintenance 
of intrahepatic progenitor cells.(17) The 792 genes 
up-regulated in EHBD organoids were enriched for 
GO terms involved in cell-cycle process and DNA 
replication, including genes such as cyclin B2/A2/E2 
and proliferating cell nuclear antigen (PCNA). This 
finding could suggest that proliferation could be con-
trolled by different mechanisms between intra- and 
extrahepatic cholangiocytes. Such differences could 
FIg. 6. Intra- and extrahepatic organoids display differences in morphology, proliferation, and self-renewal in response to GSK3β 
inhibition. (A) Images of IHBD_NO CHIR organoids transferred into either extra- or intrahepatic media (as described by Huch et al., 
2015), with or without the addition of 3 μM of CHIR 99021. (B) Number of organoids formed per 1,000 viable single cells plated from 
IHBD_NO CHIR organoids that were cultured for 7 days in either intrahepatic media (IHBD Ctrl), extrahepatic media containing 
CHIR 99201 (EHM), intrahepatic media without A 8301 or FSK (-A8301/FSK), intrahepatic media with 3  μM of CHIR 99201 
(+CHIR), intrahepatic media with 100 ng/mL of DKK1 (+DKK1), or intrahepatic media with 2.5 μM of IWP2 (+IWP2). Data were 
plotted as mean and SEM and normalized relative to IHBD ctrl conditions (n = 3 independent experiments, n = 1 IHBD donor cell 
line; one-way ANOVA). (C) Images of IHBD_NO CHIR organoids following 7 days of culture for the clonality assay. (D) Number of 
organoids formed per 1,000 viable single cells plated from EHBD organoids that were cultured for 7 days in either extrahepatic media 
containing CHIR 99021 (EHBD ctrl), extrahepatic media without A 8301 or FSK (-A8301/FSK), extrahepatic media without CHIR 
99201 (-CHIR), extrahepatic media with 100 ng/mL of DKK1 (+DKK1), or extrahepatic media with 2.5 μM of IWP2 added (+IWP2). 
Data were plotted as mean and SEM and normalized relative to EHBD ctrl (n = 9 independent experiments, n = 3 EHBD donor cell lines, 
one per region; one-way ANOVA). (E) Images of EHBD organoids following 7 days of culture for the clonality assay. **P ≤ 0.01, if not 
otherwise indicated, comparisons between groups were not significantly different (P > 0.05). Abbreviation: Ctrl, control.
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have broad implications, given that cholangiopa-
thies are associated with cholangiocyte senescence, 
and thus proliferative capacity could play an essen-
tial role in disease development.(18) In sum, these 
results demonstrate that EHBD and IHBD organ-
oids could be transcriptionally distinct. However, 
this divergence may not necessarily be associated 
with their region of origin and could be induced by 
different response to WNT and/or different culture 
conditions.
eXtRaHepatIC oRgaNoIDS 
Do Not DeMoNStRate 
DIFFeReNtIatIoN CapaCIty 
toWaRD a HepatoCyte Fate
Our gene expression analyses revealed that IHBD 
organoids might differ from EHBD organoids in 
their capacity to display a background expression 
of hepatocyte markers. Thus, we decided to vali-
date this observation by assessing the differentia-
tion capacity of EHBD versus IHBD organoids. For 
that, we used the differentiation protocol published 
by Huch et al. (Fig. 8A). As reported, under differ-
entiation conditions, IHBD_NO CHIR organoids 
showed significantly reduced expression in stem/ 
progenitor markers, suggesting differentiation 
(Fig. 8B). However, KRT19 remained stably expressed, 
suggesting that biliary identity was not completely lost. 
qPCR induction of a low-level expression of hepato-
cyte-specific markers, such as TTR, cytochrome 
P450 family 3 subfamily A member 4 (CYP3A4), 
and ALB, was also observed in IHBD_NO CHIR 
organoids. However, this was significantly lower 
than levels expressed in primary human hepatocytes. 
IHBD_CHIR organoids demonstrated identical 
trends (Supporting Fig. S13A), indicating that the 
conditions in which IHBD organoids were isolated 
and maintained did not impact their ability to express 
hepatocyte-specific markers.
We next assessed the effect of this differentiation 
protocol on EHBD organoids from all three tissue 
regions. When subjected to the differentiation pro-
tocol, EHBD organoids, similarly to IHBD organ-
oids, had significantly decreased expression of LGR5, 
PROM1, and SOX9, with stable expression of KRT19 
(Fig. 8B). However, EHBD organoids showed no 
induction of the hepatocyte-specific markers, TTR, 
ALB, or CYP3A4. These results were confirmed at 
the protein level, showing ALB expression exclusively 
in IHBD organoids (Fig. 8C and Supporting Fig. 
S13B). Given the negative results for EHBD organ-
oids, we decided to screen different culture conditions 
capable of inducing expression of hepatocyte-specific 
markers. We tested a wide variety of growth factors 
and small-molecule inhibitors aimed at perturbing 
signaling pathways important in liver development 
and regeneration (Supporting Table S5, Supporting 
Fig. S14A-C, and data not shown). None of these 
compounds significantly increased the expression of 
hepatocyte-specific markers in EHBD organoids. 
These results suggest that only biliary cells located 
within the liver have the capacity to express hepato-
cyte markers and reveal a fundamental divergence in 
terms of the capacity of differentiation between dif-
ferent regions of the biliary tree.
FIg. 7. Extra- and intrahepatic organoids are transcriptionally unique. (A) PCA of variance stabilized counts for the top 5,000 most 
variable genes between CBD (n = 6), GBD (n = 3), and PancD (n = 3) organoids as well as IHBD organoids cultured in extrahepatic 
conditions (IHBD_CHIR, n = 3) or in conditions described by Huch et al. (IHBD_NO CHIR, n = 3). (B) Sample distance matrix of the 
Pearson correlation between EHBD and IHBD organoids. (C) Venn diagram showing the number, and overlap, of genes differentially 
expressed in IHBD_CHIR organoids compared to IHBD_NO CHIR and EHBD organoids. (D) Heatmap of selected genes up-
regulated in IHBD_CHIR organoids. (E) Venn diagram showing the number, and overlap, of genes differentially expressed between 
EHBD organoids compared to the two IHBD organoid types. (F) Heatmap of the 1,393 genes differentially expressed between EHBD 
and IHBD_NO CHIR organoids as well as representative GO terms (biological process) and examples of genes up-regulated in each 
organoid type. Abbreviations: APC2, APC regulator of WNT signaling pathway 2; BMP4/7, bone morphogenetic proteins 4 and 7; C2, 
complement C2; C4A, complement C4A; C4B, complement C4B (Chido blood group); C4BPA, complement component 4 binding 
protein alpha; C6, complement C6; C7 complement C7; CCNB2/A2/E2, cyclin B2/A2/E2; COL1A1, collagen type I alpha 1 chain; 
COL1A2, collagen type I alpha 2 chain; CP, ceruloplasmin; CYP2C8, cytochrome P450 family 2 subfamily C member 8; F5, coagulation 
factor V; F11, coagulation factor XI; HSPB1, heat shock protein beta 1; HSPE1, heat shock protein family E (Hsp10) member 1; ICAM1, 
intercellular adhesion molecule 1; IL6, interleukin 6; LGR6, leucine-rich repeat–containing G-protein-coupled receptor 6; MMP2, matrix 
metalloproteinase 2; PDGFA, platelet-derived growth factor subunit A; PLK1, polo-like kinase 1; REG4, regenerating family member 4; 
SERPINA4, serpin family A member 4; SERPINA5, serpin family A member 5; TFF2, trefoil factor 2; TFF3, trefoil factor 3; WNT7A, 
Wnt family member 7A; WNT9A, Wnt family member 9A; XDH, xanthine dehydrogenase.
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Discussion
It has long been known that human cholangiop-
athies show regionalization, with many of these 
diseases targeting large EHBDs early in disease 
pathogenesis. Here, we established a transcriptional 
profile of epithelial enriched samples from CBD, 
GBD, and PancD tissues. Of note, the RNA-Seq 
data for these tissues were limited by our isolation 
technique, and the presence of nonbiliary epithelial 
cells in the samples cannot be ruled out. Despite 
this limitation, we were able to assess expression 
differences between the three tissues, gain insight 
into functional differences between the tissues, and 
identify regional tissue-specific markers such as 
HOXB2, CDX2, and SOX17. Most notably, GBD 
tissue displayed higher expression of genes associ-
ated with active metabolic processes involved in bile 
modification, including xenobiotic, lipid, and cho-
lesterol metabolism. Our data suggest that each of 
these three tissue regions display a transcriptional 
profile in line with their function in bile transport, 
while maintaining a key underlying expression of 
essential cholangiocyte-specific genes (i.e., CFTR, 
HNF1B, KRT7, and KRT19). Of these three tis-
sues, only GBD tissue has ever been previously 
sequenced.(19) Kampf et al. performed RNA-Seq 
on GBD tissue as part of the Human Protein Atlas. 
In this work, the transcriptome of GBD tissue was 
compared to 27 other human tissues, but did not 
include CBD or PancD. Our own results appear 
to be in line with their findings, given that many 
genes identified in our own data set as GBD tis-
sue specific (i.e., ATP-binding cassette subfamily C 
member 2 [ABCC2], SPP1, forkhead box L1, and 
MOGAT1) were also identified by Kampf et al. 
This lends further support to our conclusions that 
tissue-specific differences exist between these three 
extrahepatic regions. Nonetheless, future research 
is needed to understand whether these differences 
originate from the existence of different cholangio-
cytes and whether cellular diversity could play a role 
in the development of cholangiopathies.
In addition to profiling extrahepatic biliary tissues, 
we established and characterized organoids from dif-
ferent regions of the biliary tree. EHBD organoids 
were found to be transcriptionally distinct from their 
tissue of origin, increasing expression of proliferative 
and adult stem/progenitor-specific markers in vitro 
while down-regulating some functional biliary mark-
ers. This finding is contrary to other epithelial organ-
oid systems, such as intestinal organoids, which have 
been shown to maintain a high degree of similarity 
and function to their tissue of origin in vitro.(20) This 
finding is also contrary to our previously described 
ECOs, which were cultured in the presence of DKK-
1, a canonical WNT pathway inhibitor. ECOs, unlike 
the currently described EHBD organoids, maintained 
an expression profile similar to their tissue of origin 
and did not express adult stem/progenitor markers 
such as LGR5 or PROM1.(12) On the other hand, 
adding GSK3β inhibitor augments the expression of 
stem/progenitor markers in extra- and intrahepatic 
organoids, suggesting that an increase in the WNT 
signaling pathway could promote a progenitor-like 
identity. However, a number of these markers are also 
downstream of the WNT pathway, and thus their 
expression might not be a functional demonstration 
of a stem/progenitor cell state. Accordingly, EHBD 
organoids do not acquire the competence to differ-
entiate into hepatocytes even after prolonged culture 
in the presence of a GSK3β inhibitor. WNT signal-
ing therefore might only control the expression of a 
specific set of markers, which by themselves are not 
sufficient to establish multipotency. This observa-
tion reinforces recent single-cell transcriptomic stud-
ies, showing that intrahepatic cholangiocytes neither 
express canonical WNT signaling markers, including 
Lgr5, nor do they rely on canonical WNT signaling 
for ductular reaction.(21-23) Thus, expression of Lgr5, 
FIg. 8. Extrahepatic organoids do not display differentiation capacity toward a hepatocyte fate when compared to intrahepatic organoids. 
(A) Diagram depicting the differentiation protocol. (B) qPCR showing expression of biliary and hepatocyte markers in IHBD_NO CHIR, 
CBD, GBD, or PancD organoids grown in expansion media (EM) or differentiation media (DM; n = 3-11 independent experiments, 
n = 1-3 donors per tissue region). Primary hepatocytes (PH; n = 3) were used as controls. Gene expression was normalized to UBC, 
and data were plotted as mean and SEM. *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001; ****P ≤ 0.0001. (C) IF of IHBD_NO CHIR and EHBD 
organoids in DM conditions for ALB and KRT7. Abbreviations: BMP7, bone morphogenetic protein 7; DAPT, dual antiplatelet therapy; 
DEXA, dual-energy x-ray absorptiometry; FGF19, fibroblast growth factor 19; HGF, hepatocyte growth factor; NAC, N-acetylcysteine; 
NIC, nicotinamide; n.s., not significant; RSPO, R-spondin; UBC, ubiquitin C.
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which is commonly used to characterize adult stem 
cells in vitro, might not mark intrahepatic biliary pro-
genitors in vivo. Similarly, WNT canonical signaling 
might not be necessary for cholangiocyte activation in 
chronic biliary injuries. Of note, we have previously 
shown that noncanonical WNT is active in ECOs 
grown in the presence of DKK1, likely through mech-
anisms involving R-spondin, which is an essential 
additive of the culture system.(12,13) Similarly, a report 
has suggested a function for noncanonical WNT in 
ductular reactions in the mouse.(21) However, these 
findings remain controversial given that inhibition of 
WNT/planar cell polarity signaling does not affect 
intrahepatic cholangiocyte proliferation upon injury 
in the mouse and the role of this pathway seems to 
be related more to profibrotic cytokine production.(24) 
Even less is known about these processes in the 
extrahepatic biliary tree. Thus, future research should 
examine the mechanisms underpinning our observa-
tions in vitro, as well as what role canonical versus 
noncanonical WNT signaling may play in the extra-
hepatic biliary tree in vivo.
Within the intrahepatic biliary compartment, sev-
eral reports have demonstrated that intrahepatic bile 
ducts likely contain a population of bipotent progen-
itor cells capable of differentiating into hepatocyte- 
like cells after chronic injuries in vivo.(9,25) There 
have also been reports that, in the EHBDs and 
GBD, biliary cells may also be capable of differenti-
ating to hepatocyte-like cells.(26,27) However, organ-
oids derived from these two compartments have 
never been directly compared before. Here, we show 
that IHBD- and EHBD-derived organoids cannot 
be grown in the exact same culture condition in the 
presence of GSK3β inhibitor. Indeed, canonical WNT 
signaling caused IHBD organoids to cease prolifera-
tion whereas EHBD could be grown over a prolonged 
period of time in the presence of GSK3β inhibitor. 
This difference in culture requirement could explain, 
in part, the divergent transcriptional profiles uncov-
ered by our analyses and also the different capacity 
for expressing hepatocytes markers. Indeed, it has 
been shown previously that WNT produced by mac-
rophages could drive intrahepatic liver progenitor cells 
toward a hepatocyte fate during tissue injury.(28) Thus, 
the effect of CHIR 99021 on IHBD organoids could 
be reminiscent of these mechanisms. This divergence 
may originate from the embryonic origin of each of 
these tissues. Indeed, the CBD, GBD, and PancD are 
derived from a common pancreatobiliary progenitor,(3) 
whereas IHBDs are derived from bipotent hepato-
blasts, which give rise to hepatocytes and intrahe-
patic cholangiocytes.(3) This embryonic origin could 
facilitate transdifferentiation or dedifferentiation/ 
differentiation of IHBD organoids between the two 
lineages and could also explain the expression of spe-
cific markers in IHBD organoids.
In conclusion, the results presented here have 
demonstrated that regional diversity exists in the 
human biliary tree and that this regionalization could 
be lost, in part, after in vitro culture. In addition, only 
IHBD organoids seem able to acquire, in specific con-
ditions, the capacity to express hepatocyte markers. 
Thus, fundamental differences exist between intra- 
and extrahepatic biliary epithelia, which are not erased 
by in vitro culture and which are defined by their 
anatomical location and also their embryonic origin. 
These results may provide insight into understand-
ing the regionalization of human cholangiopathies. 
Finally, it is important for future research to exam-
ine what role the anatomical niche occupied by these 
different biliary cell types may play in shaping their 
expression profile, given that it may control regenera-
tive processes during liver and/or biliary disease.
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